ICU Medical
Market Cap
US$3.3b
Last Updated
2019/09/18 23:35 UTC
Data Sources
Company Financials +
Executive Summary
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide.
Snowflake
Fundamentals
Flawless balance sheet and fair value.
Risks
- ICU Medical has significant price volatility in the past 3 months.
Similar Companies
Share Price & News
How has ICU Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
-0.1%
NasdaqGS:ICUI
0.5%
US Medical Equipment
-0.02%
US Market
1 Year Return
-39.8%
NasdaqGS:ICUI
9.9%
US Medical Equipment
1.6%
US Market
ICUI underperformed the Medical Equipment industry which returned 9.7% over the past year.
ICUI underperformed the Market in United States of America which returned 1.9% over the past year.
Share holder returns
| ICUI | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.1% | 0.5% | -0.02% |
| 30 Day | -3.4% | 0.09% | 2.7% |
| 90 Day | -35.2% | 2.0% | 1.4% |
| 1 Year | -39.8%-39.8% | 10.8%9.9% | 3.8%1.6% |
| 3 Year | 28.1%28.1% | 69.0%63.9% | 45.2%35.8% |
| 5 Year | 154.1%154.1% | 136.2%109.3% | 61.8%44.1% |
Price Volatility Vs. Market
How volatile is ICU Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 day ago | Simply Wall St
Should You Be Concerned About ICU Medical, Inc.'s (NASDAQ:ICUI) Historical Volatility?1 week ago | Simply Wall St
Corporate VP Virginia Sanzone Just Sold A Bunch Of Shares In ICU Medical, Inc. (NASDAQ:ICUI)3 weeks ago | Simply Wall St
Are Investors Undervaluing ICU Medical, Inc. (NASDAQ:ICUI) By 47%?Valuation
Is ICU Medical undervalued based on future cash flows and its price relative to the stock market?
47%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
ICU Medical's share price is below the future cash flow value, and at a moderate discount (> 20%).
ICU Medical's share price is below the future cash flow value, and at a substantial discount (> 40%).
Price Based on Earnings
ICU Medical is overvalued based on earnings compared to the US Medical Equipment industry average.
ICU Medical is overvalued based on earnings compared to the United States of America market.
Price Based on Expected Growth
ICU Medical is poor value based on expected growth next year.
Price Based on Value of Assets
ICU Medical is good value based on assets compared to the US Medical Equipment industry average.
Next Steps
Future Growth
How is ICU Medical expected to perform in the next 1 to 3 years based on estimates from 4 analysts?
38.7%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
ICU Medical's revenue is expected to grow by 0.1% yearly, however this is not considered high growth (20% yearly).
ICU Medical's earnings are expected to grow significantly at over 20% yearly.
ICU Medical's revenue growth is positive but not above the United States of America market average.
ICU Medical's earnings growth is expected to exceed the United States of America market average.
ICU Medical's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Earnings per Share Growth Estimates
Future Return on Equity
ICU Medical is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
Next Steps
Past Performance
How has ICU Medical performed over the past 5 years?
9.4%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
ICU Medical's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
ICU Medical's 1-year earnings growth is negative, it can't be compared to the 5-year average.
ICU Medical's 1-year earnings growth is negative, it can't be compared to the US Medical Equipment industry average.
Return on Equity
ICU Medical has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
Return on Assets
ICU Medical used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.
Return on Capital Employed
ICU Medical's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
Next Steps
Financial Health
How is ICU Medical's financial position?
Financial Position Analysis
ICU Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
ICU Medical's cash and other short term assets cover its long term commitments.
Debt to Equity History and Analysis
ICU Medical has no debt.
ICU Medical currently has no debt however we can't compare to 5 years ago as we have no data for that period.
ICU Medical has no debt, it does not need to be covered by operating cash flow.
ICU Medical has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
High level of physical assets or inventory.
ICU Medical has no debt, it does not need to be covered by short term assets.
Next Steps
Dividend
What is ICU Medical's current dividend yield, its reliability and sustainability?
Dividend Yield and Payments Analysis
Unable to evaluate ICU Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate ICU Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.
Unable to perform a dividend volatility check as ICU Medical has not reported any payouts.
Unable to verify if ICU Medical's dividend has been increasing as the company has not reported any payouts.
Current Payout to Shareholders
Unable to calculate sustainability of dividends as ICU Medical has not reported any payouts.
Future Payout to Shareholders
Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
Next Steps
Management
What is the CEO of ICU Medical's salary, the management and board of directors tenure and is there insider trading?
2.6yrs
Average management tenure
CEO
Vivek Jain (47yo)
5.6yrs
Tenure
US$5,962,408
Compensation
Mr. Vivek Jain has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr. Jain served as the President of Procedural Solutions at CareFusion Corporation from August 201 ...
CEO Compensation Analysis
Vivek's remuneration is about average for companies of similar size in United States of America.
Vivek's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Management Age and Tenure
2.6yrs
Average Tenure
53.5yo
Average Age
The tenure for the ICU Medical management team is about average.
Board Age and Tenure
4.6yrs
Average Tenure
58yo
Average Age
The tenure for the ICU Medical board of directors is about average.
Insider Trading
ICU Medical individual insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Chief Legal Officer Corporate VP |
| Shares | 3,000 |
| Max Price | US$154.08 |
| Entity | Individual |
| Role | Controller Controller |
| Shares | 3,101 |
| Max Price | US$231.89 |
| Entity | Individual |
| Role | Chief Operating Officer Chief Operating Officer |
| Shares | 5,348 |
| Max Price | US$228.07 |
| Entity | Individual |
| Role | Member of the Board of Directors Independent Director |
| Shares | 1,464 |
| Max Price | US$234.65 |
| Entity | Company |
| Shares | 2,500,000 |
| Max Price | US$209.25 |
Ownership Breakdown
Management Team
Steve Riggs (60yo)
Executive Officer of Special Project Opertions
- Tenure: 0yrs
- Compensation: US$1.05m
Scott Lamb (56yo)
CFO & Treasurer
- Tenure: 11.6yrs
- Compensation: US$1.63m
Vivek Jain (47yo)
Chairman of the Board & CEO
- Tenure: 5.6yrs
- Compensation: US$5.96m
Kevin McGrody
Controller
- Tenure: 0yrs
Tom McCall (61yo)
Corporate Vice President of Marketing & Communications and GM of Critical Care
- Tenure: 2.6yrs
- Compensation: US$980.28k
Virginia Sanzone (44yo)
Corporate VP
- Tenure: 1.7yrs
- Compensation: US$1.47m
Christian Voigtlander (51yo)
Chief Operating Officer
- Tenure: 1.7yrs
- Compensation: US$2.74m
Board Members
Elisha Finney (58yo)
Independent Director
- Tenure: 3.7yrs
- Compensation: US$267.05k
George Lopez (71yo)
Director
- Tenure: 35.7yrs
- Compensation: US$368.15k
Robert Swinney (73yo)
Independent Director
- Tenure: 21.7yrs
- Compensation: US$256.30k
David Hoffmeister (64yo)
Independent Director
- Tenure: 1.7yrs
- Compensation: US$240.05k
Vivek Jain (47yo)
Chairman of the Board & CEO
- Tenure: 5.6yrs
- Compensation: US$5.96m
David Greenberg (52yo)
Lead Independent Director
- Tenure: 0yrs
- Compensation: US$271.05k
Don Abbey (52yo)
Independent Director
- Tenure: 1.7yrs
- Compensation: US$240.05k
Company Information
ICU Medical, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: ICU Medical, Inc.
- Ticker: ICUI
- Exchange: NasdaqGS
- Founded: 1984
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$3.322b
- Shares outstanding: 20.67m
- Website: https://www.icumed.com
Number of Employees
Location
- ICU Medical, Inc.
- 951 Calle Amanecer
- San Clemente
- California
- 92673
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ICUI | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Mar 1992 |
| IC7 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Mar 1992 |
Biography
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube runni ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/09/18 23:35 |
| End of Day Share Price | 2019/09/18 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.